⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Leucadia Therapeutics

Name: Leucadia Therapeutics - AI Visibility Score
Creator: Engagemii
Published: 2026-06-28T01:53:36.406Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

leucadiatx.com

X f

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Leucadia Therapeutics just got measured.

5/10 means Leucadia Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Leucadia Therapeutics

Leucadia Therapeutics is working to make Alzheimer's Disease a lost memory.

Key Topics

HEARTBREAK IS…

Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works.

We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward, we intend to use Arethusta to prevent and cure Alzheimer’s itself. Our work is attracting significant attention.

LEARN MORE

Project Cribrose will help us refine our proprietary diagnostic tools to more precisely determine the likelihood of a patient developing Alzheimer’s disease. Participants will sit for a 20-second CT scan and undergo a battery of cognitive tests developed by Leucadia Therapeutics. Project Cribrose is a collaboration with neurosurgeons at Arrowhead Regional Medical Center in Colton, California.